Ali Tehrani

Ali Tehrani was the founder of Zymeworks BC, Inc., founded in 2003, holding the titles of President, Chief Executive Officer & Director from 2003 to 2022.
Dr. Tehrani is also the founder of Student Biotechnology Network.
Current jobs include Director at BIOTECanada since 2021, Director at Consortium Québécois sur la Découverte du Médicament, Director at Creatus Biosciences, Inc. since 2015, Director at Reverb Therapeutics, Inc. since 2023, Partner at Amplitude Ventures since 2023, and Board Member at Qurcan Therapeutics, Inc. since 2022.
Former jobs include President & Chief Executive Officer at Zymeworks, Inc. from 2013 to 2022, Director at LifeSciences British Columbia, and Council Member at Premier's Technology Council from 2016 to 2018.
Education includes a doctorate from the University of British Columbia conferred in 2003, and undergraduate and graduate degrees from the University of Massachusetts conferred in 1994 and 1996 respectively.